Filing Details
- Accession Number:
- 0001849682-23-000002
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-03-08 16:58:33
- Reporting Period:
- 2022-08-16
- Accepted Time:
- 2023-03-08 16:58:33
- Original Submission Date:
- 2022-08-17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1599298 | Summit Therapeutics Inc. | SMMT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1849682 | Ankur Dhingra | C/O Summit Therapeutics Inc. 2882 Sand Hill Road, Suite 106 Menlo Park CA 94025 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-16 | 13,027 | $0.97 | 39,527 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-08-16 | 24,658 | $0.97 | 38,196 | No | 4 | P | Indirect | By Dhingra Family Revocable Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | By Dhingra Family Revocable Trust |
Footnotes
- This Form 4 is being amended to correct the number of shares purchased by the Reporting Person in the Issuer's rights offering. 1,470 shares were inadvertently omitted from the original filing.
- The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
